Lea, C K <br/><br/>
Androstenedione treatment reduces loss of cancellous bone volume in ovariectomised rats in a dose-responsive manner and the effect is not mediated by oestrogen.  [electronic resource] 

 -  The Journal of endocrinology  Feb 1998 
 - 331-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-0795 
<br/><br/><label>Standard No.: </label>10.1677/joe.0.1560331  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androstenedione--blood<br/>Animals<br/>Bone Remodeling--drug effects<br/>Delayed-Action Preparations<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Estradiol--blood<br/>Female<br/>Humans<br/>Osteoporosis, Postmenopausal--drug therapy<br/>Ovariectomy<br/>Rats<br/>Rats, Sprague-Dawley<br/>Testosterone--blood